Holen Sie sich die Stockscreener-App
55.48
3.12%
1.68
Schlusskurs vom Vortag:
$53.80
Offen:
$52.98
24-Stunden-Volumen:
322.26K
Relative Volume:
1.18
Marktkapitalisierung:
$2.25B
Einnahmen:
$1.46B
Nettoeinkommen (Verlust:
$92.09M
KGV:
24.60
EPS:
2.2555
Netto-Cashflow:
$47.29M
1W Leistung:
+5.66%
1M Leistung:
+7.81%
6M Leistung:
+45.05%
1J Leistung:
+151.50%
1-Tages-Spanne:
$52.41
$55.67
1-Wochen-Bereich:
$49.89
$55.67
52-Wochen-Spanne:
$16.16
$56.30
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
55.48 | 2.25B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis - Defense World
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells $272,764.80 in Stock - Defense World
Is It Too Late To Consider Phibro Animal Health (PAHC) After Its 143% One Year Surge? - Yahoo Finance
PAHC Earnings History & Surprises | EPS & Revenue Results | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million By Investing.com - Investing.com South Africa
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million - Investing.com Australia
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 10,560 Shares of Stock - MarketBeat
Phibro Animal Health (PAHC) CEO-linked BFI Co. sells 22,880 shares in Rule 10b5-1 trades - Stock Titan
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Volatility Watch: Is Phibro Animal Health Corporation gaining market shareOil Prices & Weekly Setup with ROI Potential - baoquankhu1.vn
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares By Investing.com - Investing.com South Africa
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares - Investing.com
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 5,280 Shares - MarketBeat
BFI Co. tied to Phibro Animal Health (PAHC) converts and sells shares - Stock Titan
A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Gains - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Zacks Research - Defense World
Multiple resale transactions by affiliate reported for Phibro Animal Health (PAHC) - Stock Titan
Zacks Research Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy - MarketBeat
Is PAHC Stock a Solid Investment Opportunity Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 12th - Yahoo Finance
Looking for earnings beat? Buy these 4 top-ranked stocks - MSN
EPS Watch: Will Phibro Animal Health Corporation benefit from AI trends2026 Momentum Check & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Community Health Systems Attractive Despite Its Heavy Debt Load? - TradingView
Is It Too Late To Consider Phibro Animal Health (PAHC) After 1-Year Share Price Surge? - simplywall.st
How risky is Phibro Animal Health Corporation stock nowJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - Naître et grandir
Phibro Animal Health Corporation $PAHC Shares Sold by Vanguard Group Inc. - MarketBeat
How The Investment Story Is Shifting For Phibro Animal Health (PAHC) After Fresh Analyst Targets - Yahoo Finance
Here's Why Ensign Group Shares Are Attracting Investors Now - TradingView
How To YieldBoost PAHC To 15.4% Using Options - Nasdaq
Ex-Dividend Reminder: Phibro Animal Health, Pjt Partners and Equitable Holdings - Nasdaq
Phibro Animal Health Raises Guidance at BofA Conference as Zoetis MFA Integration Advances - Yahoo Finance
Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell? - Yahoo Finance
Zacks.com featured highlights include Crocs, LATAM Airlines, Arrow Electronics and Phibro Animal Health - Yahoo Finance
Phibro Animal Health (PAHC) director sells $1.1 million in stock By Investing.com - Investing.com South Africa
Phibro Animal Health (PAHC) director sells $1.1 million in stock - Investing.com Nigeria
Phibro Animal Health (PAHC) CEO-linked LLC sells 21,120 shares - Stock Titan
Phibro at BofA Securities Summit: Strategic Growth and Integration - Investing.com
Jack Bendheim Sells 7,040 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - Defense World
Phibro Animal Health Corp. Achieves 124.29% Return, Emerging as a Multibagger in Pharmaceuticals Sector - Markets Mojo
Insider entity BFI Co. LLC trims Phibro Animal Health (PAHC) stake - Stock Titan
What Phibro Animal Health (PAHC)'s Stronger Q2 and Maturing Feed Additive Portfolio Mean For Shareholders - Yahoo Finance
PAHC Technical Analysis & ETF Price Forecast - Intellectia AI
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - Yahoo Finance
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - The Motley Fool
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Best Momentum Stocks to Buy for February 20th - Yahoo Finance
Best Value Stocks to Buy for February 20th - Yahoo Finance
Assessing Phibro Animal Health (PAHC) Valuation After Strong Share Price Momentum - Yahoo Finance
Zacks Research Issues Positive Forecast for PAHC Earnings - MarketBeat
Weekly Earnings: Is Phibro Animal Health Corporation forming a breakout patternBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):